2D icons › Cancer
Cancer: 231 flat 2D icons
Flat vector icons drawn by BioDiorama, free to use with no credit required. Every colour is a setting, many have further settings, and they export as real vector in layered SVG, PDF and editable PowerPoint. Open the 2D Studio and type the name into the search box.
Cancer cells · Cancer cell states · Tumours · Tumour in tissue · Genome & evolution · Cell states & plasticity · Metastatic cascade · Metastatic disease · Tumour microenvironment · Hypoxia & metabolism · Angiogenesis & vessels · Surgery & ablation · Radiotherapy · Chemotherapy actions · Targeted therapy · Cell & immune therapy · Resistance · Side effects · Breast & gynaecological tumours · Digestive tumours · Thoracic, urological & endocrine tumours · Skin, brain, bone & childhood tumours · Blood cancers · Mouse tumour models · Genetic & carcinogen mouse models · Other tumour models · Measuring tumours · Screening & diagnosis · Staging & grading · Causes & risk
Cancer cells 18
Cancer cell (small, round)
Cancer cell (large, irregular)
Cancer cell (spiky, with protrusions)
Carcinoma cell (polygonal epithelial)
Spindle cancer cell (sarcoma)
Giant multinucleated tumour cell
Signet ring cell
Reed–Sternberg cell
Leukaemic blast with Auer rods
Cancer stem cell
Hairy cell (hairy cell leukaemia)
Clear cell carcinoma cells
Small cell carcinoma (oat cells)
Melanoma cell
Glioblastoma cell
Koilocyte (HPV-infected cell)
Abnormal tripolar mitosis
Cancer cell with organelles
Cancer cell states 12
Dividing cancer cell
Cancer cell dying by apoptosis
Tumour necrosis
Dormant cancer cell
Invading cancer cell (squeezing through the matrix)
Drug-resistant cancer cell (efflux pumps)
Hypoxic cancer cell (HIF-1α)
Therapy-induced senescent cancer cell
Warburg effect (aerobic glycolysis)
Cancer cell with micronuclei (chromosomal instability)
Cancer cell overexpressing a receptor (HER2)
Cancer cell releasing exosomes
Tumours 8
Cancer cell cluster (mixed sizes)
Tumour spheroid
Tumour spheroid (section): necrotic core
Solid tumour with blood vessels
Tumour angiogenesis (VEGF)
Tumour growth
Tumour heterogeneity (clones)
Clonal evolution
Tumour in tissue 11
Normal epithelium
Hyperplasia
Dysplasia
Carcinoma in situ
Invasive carcinoma
Cancer progression (normal to invasive)
Benign tumour (encapsulated)
Malignant tumour (invasive)
Colon polyp (adenoma)
Polyp to carcinoma sequence
Squamous cell carcinoma (keratin pearl)
Genome & evolution 6
Hallmarks of cancer wheel
Two-hit inactivation of a tumour suppressor
Tumour phylogenetic tree (truncal and branch mutations)
Chromothripsis (shattered and rejoined chromosome)
Microsatellite instability (shifted repeat peaks)
Oncoprint of recurrent alterations
Cell states & plasticity 11
EMT spectrum (epithelial, hybrid, mesenchymal)
Mesenchymal–epithelial transition at a metastatic site
Cancer stem cell hierarchy
Perivascular cancer stem cell niche
Collective invasion led by leader cells
Amoeboid cancer cell migration through collagen
Tumour budding at the invasive front
Entosis (cell-in-cell)
Drug-tolerant persister cells
Anoikis resistance (survival after detachment)
Cancer cell–macrophage fusion hybrid
Metastatic cascade 9
Cancer cell breaching the basement membrane
Invadopodium degrading matrix (MT1-MMP)
Intravasation at a TMEM doorway
Circulating tumour cell cloaked by platelets
Circulating tumour cell cluster with a neutrophil
Tumour cell arrested in a capillary
Tumour cell extravasation
Metastatic colonisation of the lung
Pre-metastatic niche
Metastatic disease 4
Lymphatic spread to a sentinel lymph node
Osteolytic bone metastasis (vicious cycle)
Perineural invasion
Lymphovascular invasion (tumour embolus)
Tumour microenvironment 17
Tumour microenvironment (cell types)
Myofibroblastic CAF (myCAF) wrapping a tumour nest
Inflammatory CAF (iCAF) secreting IL-6
Antigen-presenting CAF (apCAF) with MHC II
TAM–tumour cell EGF/CSF-1 paracrine loop
MDSCs suppressing a T cell
Treg depriving an effector T cell of IL-2
Tertiary lymphoid structure in a tumour
Neutrophil extracellular traps capturing tumour cells
Normal and tumour vascular networks
Tumour-associated collagen signature (TACS-3)
Desmoplastic stroma around pancreatic cancer glands
Inflamed, excluded and desert tumours
Cancer-associated adipocytes feeding tumour cells
Cancer–immunity cycle
Neuron–glioma synapse
Fusobacterium in colorectal cancer
Hypoxia & metabolism 8
Oxygen gradient away from a tumour vessel
Pseudopalisading necrosis (glioblastoma)
Acidic tumour microenvironment (lactate and H⁺ export)
Metabolic symbiosis (lactate shuttle)
Glutamine addiction (glutaminolysis feeding the TCA cycle)
Glucose competition between tumour cells and T cells
Mutant IDH producing the oncometabolite 2-HG
Cancer-associated thrombosis (tissue factor)
Angiogenesis & vessels 7
Angiogenic switch
Vessel co-option by tumour cells
Vasculogenic mimicry
Intussusceptive angiogenesis (pillar splitting)
Vessel normalisation by anti-VEGF therapy
Glomeruloid microvascular proliferation
Tumour lymphangiogenesis (VEGF-C)
Surgery & ablation 9
Resection margin status (R0 and R1)
Sentinel lymph node biopsy (blue dye and gamma probe)
Mohs micrographic surgery (layer-by-layer excision)
Radiofrequency ablation with an umbrella electrode
Microwave ablation of a lung tumour
Cryoablation ice ball around a kidney tumour
High-intensity focused ultrasound (HIFU)
Radioembolisation with Y-90 microspheres
Irreversible electroporation (NanoKnife)
Radiotherapy 2
Proton Bragg peak versus photon depth dose
Radioligand therapy (¹⁷⁷Lu-PSMA)
Chemotherapy actions 11
DNA interstrand crosslinks (alkylating agent)
Platinum adduct bending DNA
Antimetabolite stalling DNA synthesis
Topoisomerase II trapped on cleaved DNA
Taxane stabilising microtubules (mitotic arrest)
Vinca alkaloid blocking microtubule assembly
Anthracycline intercalating between base pairs
Log-kill with repeated chemotherapy cycles
Neutrophil nadir after a chemotherapy cycle
Immunogenic cell death (calreticulin, ATP, HMGB1)
Tumour lysis syndrome
Targeted therapy 9
PARP inhibitor synthetic lethality in BRCA-mutant cells
CDK4/6 inhibitor holding cells in G1
Oestrogen receptor blocked in a breast cancer cell
Antibody–drug conjugate: binding, uptake and payload release
Antibody-dependent cellular cytotoxicity against a HER2 tumour cell
Anti-VEGF antibody sequestering VEGF
BCL-2 inhibitor freeing BAX at the mitochondrion
Differentiation therapy of APL with ATRA
Proteasome inhibitor in a myeloma cell
Cell & immune therapy 8
Tumour-infiltrating lymphocyte (TIL) therapy
CAR-NK cell
Dendritic cell vaccine
Personalised neoantigen mRNA vaccine
Oncolytic virus bursting a tumour cell
Anti-PD-1 antibody restoring T-cell killing
Repolarising tumour-associated macrophages (M2 to M1)
Autologous stem cell transplant cycle
Resistance 8
Gatekeeper mutation blocking a kinase inhibitor
Bypass signalling through MET amplification
CD19-negative relapse after CAR-T therapy
Lineage plasticity to neuroendocrine cancer
Selection of a pre-existing resistant clone
BRCA reversion mutation restoring repair
Fibroblast-secreted HGF protecting tumour cells from a drug
Blood–brain barrier as a drug sanctuary
Side effects 1
Chemotherapy-induced hair loss (anagen effluvium)
Breast & gynaecological tumours 3
Invasive ductal carcinoma of the breast (histology)
Invasive lobular carcinoma (single-file cells)
Cervical intraepithelial neoplasia grades (CIN 1–3)
Digestive tumours 2
Barrett's oesophagus with early adenocarcinoma (endoscopy)
Neuroendocrine tumour (nests, salt-and-pepper chromatin)
Thoracic, urological & endocrine tumours 3
Lung adenocarcinoma (lepidic growth along alveoli)
Papillary urothelial carcinoma (bladder fronds)
Gleason patterns 3, 4 and 5 (prostate cancer)
Skin, brain, bone & childhood tumours 4
Basal cell carcinoma (peripheral palisading)
Cutaneous melanoma (asymmetric, irregular border)
Meningothelial whorls and psammoma bodies (meningioma)
Medulloblastoma (Homer Wright rosettes)
Blood cancers 4
Follicular lymphoma (back-to-back follicles)
Chronic myeloid leukaemia blood film (granulocytes at all stages)
Acute lymphoblastic leukaemia blood film (lymphoblasts)
Chronic lymphocytic leukaemia blood film (smudge cells)
Mouse tumour models 12
Cell-line-derived xenograft (CDX) injection into the flank
Patient-derived xenograft (PDX) fragment implantation
Serial PDX passaging (P0 to P2)
Orthotopic injection into the mammary fat pad
Orthotopic pancreatic tumour implantation (laparotomy)
Experimental lung metastasis after tail-vein injection
Intracardiac injection for bone metastasis
Intrasplenic injection for liver metastasis
Excised tumours lined up by treatment group
Dorsal skinfold window chamber for intravital imaging
Mouse with malignant ascites
Bilateral flank tumours (irradiated and distant)
Genetic & carcinogen mouse models 7
Genetically engineered mouse model (Cre-activated Kras and p53)
MMTV-PyMT mouse with multiple mammary tumours
Syngeneic tumour in an immunocompetent mouse
Humanised mouse (human CD34⁺ cells engrafted in NSG)
ApcMin intestinal polyps (Swiss roll)
DMBA/TPA skin papillomas on a shaved back
AOM/DSS colitis-associated colon tumours
Other tumour models 10
Zebrafish larval xenograft
Chick chorioallantoic membrane (CAM) tumour assay
Drosophila eye-disc tumour (RasV12 scrib clones)
Patient-derived tumour organoid (PDO)
Tumour organoid drug screen (response heat map)
Tumour organoid and T-cell co-culture
Precision-cut tumour slice culture
Microfluidic extravasation assay
Soft agar colony formation (anchorage-independent growth)
Cell line authentication by STR profiling
Measuring tumours 8
Tumour volume from length and width (V = L × W² / 2)
Bioluminescence signal growing over weeks
Ki-67 immunohistochemistry (proliferation index)
Blood tube for cell-free DNA (plasma separated)
Tumour cells shedding ctDNA into the blood
Cell-free DNA fragment-size profile (167 bp peak)
Circulating tumour cells captured on an antibody-coated micropost chip
Serum tumour marker falling and rising (CA-125)
Screening & diagnosis 4
Pap smear with high-grade squamous lesion (HSIL) cells
Cervical screening sample (brush and liquid cytology vial)
Faecal immunochemical test (FIT) kit
Hereditary breast and ovarian cancer pedigree
Staging & grading 6
T stage by depth of invasion in the bowel wall
N stage by number of involved lymph nodes
Breast tumour size categories (T1, T2, T3)
Breslow thickness of a melanoma
Tumour grade by differentiation (G1, G2, G3)
Cancer stages from I to IV (local to distant)
Causes & risk 9
Tobacco smoke carcinogens reaching the airway lining
Ultraviolet light reaching epidermal keratinocytes
HPV E6 and E7 disabling p53 and Rb
Correa cascade (gastritis to gastric cancer)
Chronic hepatitis to cirrhosis to liver cancer
Asbestos body in lung tissue
Aflatoxin-producing mould on stored peanuts
Familial adenomatous polyposis (colon carpeted with polyps)
Field cancerisation in the oral mucosa